Market Tracker

06/28 4:24am ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.60
Delayed Data
As of Jun 27
 -0.37 / -9.32%
Today’s Change
3.18
Today|||52-Week Range
10.98
-16.47%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close3.97
Today’s open3.97
Day’s range3.56 - 4.02
Volume635,599
Average volume (3 months)260,066
Market cap$195.5M
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+61.90%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...-0.09-1.62%
CDXSCodexis Inc-0.15-2.88%
ARWRArrowhead Pharmaceut...0.000.00%
BCLIBrainstorm Cell Ther...-0.19-4.32%
Data as of 06/27/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts